Results
|
10941.
|
|
|
10942.
|
Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP. [electronic resource] by
- Kim, Min Kyoung
- Kim, Shin
- Lee, Sung Sook
- Sym, Sun Jin
- Lee, Dae Ho
- Kim, Sang We
- Jang, Seongsoo
- Park, Chan Jeong
- Chi, Hyun Sook
- Huh, Jooryung
- Suh, Cheolwon
Producer: 20070830
In:
Transfusion vol. 47
Availability: No items available.
|
|
10943.
|
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy. [electronic resource] by
- Aichberger, K J
- Herndlhofer, S
- Agis, H
- Sperr, W R
- Esterbauer, H
- Rabitsch, W
- Knöbl, P
- Haas, O A
- Thalhammer, R
- Schwarzinger, I
- Sillaber, C
- Jäger, U
- Valent, P
Producer: 20080314
In:
European journal of clinical investigation vol. 37
Availability: No items available.
|
|
10944.
|
|
|
10945.
|
|
|
10946.
|
|
|
10947.
|
Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience. [electronic resource] by
- Melillo, Lorella
- Valente, D
- D'Arena, G
- Dell'Olio, M
- Falcone, A
- Minervini, M M
- Nobile, M
- Rossi, G
- Sanpaolo, G
- Scalzulli, P R
- Cascavilla, N
Producer: 20111202
In:
International journal of immunopathology and pharmacology vol. 24
Availability: No items available.
|
|
10948.
|
|
|
10949.
|
|
|
10950.
|
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome. [electronic resource] by
- Jabbour, Elias
- Kantarjian, Hagop
- Ravandi, Farhad
- Garcia-Manero, Guillermo
- Estrov, Zeev
- Verstovsek, Srdan
- O'Brien, Susan
- Faderl, Stefan
- Thomas, Deborah A
- Wright, John J
- Cortes, Jorge
Producer: 20110512
In:
Cancer vol. 117
Availability: No items available.
|
|
10951.
|
|
|
10952.
|
|
|
10953.
|
|
|
10954.
|
|
|
10955.
|
|
|
10956.
|
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. [electronic resource] by
- Megías-Vericat, Juan Eduardo
- Montesinos, Pau
- Herrero, María José
- Moscardó, Federico
- Bosó, Virginia
- Martínez-Cuadrón, David
- Rojas, Luis
- Rodríguez-Veiga, Rebeca
- Boluda, Blanca
- Sendra, Luis
- Cervera, José
- Poveda, José Luis
- Sanz, Miguel Ángel
- Aliño, Salvador F
Producer: 20180423
In:
Leukemia & lymphoma vol. 58
Availability: No items available.
|
|
10957.
|
|
|
10958.
|
|
|
10959.
|
|
|
10960.
|
[Drug treatment of acute myelogenous leukaemia. Current options and future perspectives]. [electronic resource] by
- Telek, Béla
- Rejtő, László
- Batár, Péter
- Miltényi, Zsófia
- Reményi, Gyula
- Simon, Zsófia
- Ujj, Zsófia
- Mezei, Gabriella
- Szász, Róbert
- Kiss, Attila
- Udvardy, Miklós
- Illés, Árpád
Producer: 20160727
In:
Orvosi hetilap vol. 157
Availability: No items available.
|